natgillin/translations-raw huggingface dataset:
are taking the contraceptive pill or hormone replacement therapy;
če jemljete kontracepcijske tablete ali hormonsko nadomestno zdravljenje,
Are taking the herbal remedy St John’s Wort
Jemljete zeliščni pripravek, ki vsebuje šentjanževko
are taking treatment for human immunodeficiency virus (HIV) infection, since your doctor may want to monitor you more closely.
e zdravite za okužbo z virusom humane imunske pomanjkljivosti (HIV), ker vas bo morda zdravnik spremljal bolj skrbno.
Are the Numbers 1, 2 & 3 how I select my dose of medicine?
Ali s številkami 1, 2 in 3 nastavim odmerek zdravila?
are to be used when oestrogen
Pri bolnikih, ki prejemajo zdravilo
are used for heart problems and complications (such as digoxin), or for thinning the blood (such as warfarin).
e uporabljajo za zdravljenje težav in zapletov s srcem (kot je digoksin) ali za redčenje krvi (kot je varfarin);
are vomiting, have recently had severe vomiting, or have diarrhoea
bruhate ali ste pred kratkim veliko bruhali ali imate drisko,
are vomiting, have recently had severe vomiting, or have diarrhoea.
bruhate ali ste pred kratkim veliko bruhali ali imate drisko,
Are you exercising more than usual?
Ali ste telesno bolj dejavni kot običajno?
Are you familiar with the technique of self injection or have you discussed this with your doctor (or nurse or pharmacist)?
Ste seznanjeni s tehniko samoinjiciranja oziroma ste se o tem pogovorili s svojim zdravnikom (ali medicinsko sestro ali farmacevtom)?
Are you taking any medicines containing: azathioprine or other immunosuppressive agents (which are sometimes given to patients after a transplant operation), cholestyramine (used to treat patients with high blood cholesterol), rifampicin (antibiotic), antacids or proton pump inhibitors (used for acid problem in your stomach such as indigestion), phosphate binders (used in patients with chronic kidney failure to reduce the absorption of phosphate) or any other medicines (including those you can buy without a prescription) that your doctor does not know about?
Ali morda jemljete zdravila, ki vsebujejo azatioprin ali druga imunosupresivna zdravila (bolniki jih včasih prejmejo po presaditveni operaciji), holestiramin (uporabljajo ga za zdravljenje bolnikov z visokim holesterolom), rifampicin (antibiotik), antacide ali zaviralce protonske črpalke (uporabljajo se pri težavah s kislino v želodcu, kot je dispepsija), fosfatne vezalce (uporabljajo jih za zmanjšanje absorpcije fosfatov pri bolnikih s kronično ledvično odpovedjo) ali druga zdravila (vključno s tistimi, ki ste jih dobili brez recepta), za katera vaš zdravnik ne ve?
Are you taking any medicines containing: azathioprine or other immunosuppressive agents (which are sometimes given to patients after a transplant operation), cholestyramine (used to treat patients with high blood cholesterol), rifampicin (antibiotic), antacids or proton pump inhibitors (used for acid problem in your stomach such as indigestion), phosphate binders (used in patients with chronic kidney failure to reduce the absorption of phosphate), or any other medicines (including those you can buy without a prescription) that your doctor does not know about?
Ali morda jemljete zdravila, ki vsebujejo azatioprin ali druga imunosupresivna zdravila (bolniki jih včasih prejmejo po presaditveni operaciji), holestiramin (uporabljajo ga za zdravljenje bolnikov z visokim holesterolom), rifampicin (antibiotik), antacide ali zaviralce protonske črpalke (uporabljajo se pri težavah s kislino v želodcu, kot je dispepsija), fosfatne vezalce (uporabljajo jih za zmanjšanje absorpcije fosfatov pri bolnikih s kronično ledvično odpovedjo) ali druga zdravila (vključno s tistimi, ki ste jih dobili brez recepta), za katera vaš zdravnik ne ve?
are  8 years of age and weigh 43.8 kg or more
o stari  8 let in imajo telesno maso 43,8 kg ali več,
are  8 years of age and weigh 43.8 kg or more or
o stari  8 let in imajo telesno maso 43,8 kg ali več ali
are, or become dehydrated
te ali postanete dehidrirani
Area (m2)
površina (m )
AREA 4
PREDEL 4.
Area in card for physician to record skin type and date of injection.
V bolnikovi izkaznici je predviden prostor, v katerega zdravnik vnese tip kože in datum injiciranja.
area of upper arms
del nadlaktov.
Area under the curve** Glucose Infusion Rate p-value < 0.001 for all comparisons with Levemir
Površina pod krivuljo ** Hitrost infuzije glukoze p-vrednost < 0,001 za vse primerjave z zdravilom Levemir
Area under the curve: 587.88 ± 1.63 (% x h)
Površina pod krivuljo: 587,88 ± 1,63 (% x h)
Area under the plasma concentration curve (AUC) of ertapenem in adults increases nearly dose- proportionally over the 0.5 to 2 g dose range.
Površina pod krivuljo plazemske koncentracije (AUC) se pri odraslih pri ertapenemu v območju odmerkov 0,5 do 2 g povečuje skoraj sorazmerno z odmerkom.
area. d Patients in whom the first treatment course did lead to complete clearance and who had a recurrence in the treatment area at either week 26 or 44.
anatomski predel (obraz ali lasišče) in državo. c Bolniki, pri katerih v prvem ciklu zdravljenja niso dosegli popolne ozdravitve vseh aktiničnih keratoz na zdravljenem predelu. d Bolniki, pri katerih so v prvem ciklu zdravljenja dosegli popolno ozdravitev, vendar so v 26. ali 44. tednu ugotovili ponovitev bolezni.
area. d Patients in whom the first treatment course did lead to complete clearance and who had a recurrence in the treatment area at either week 26 or 44.
anatomski predel (obraz ali lasišče) in državo. c Bolniki, pri katerih v prvem krogu zdravljenja niso dosegli popolne ozdravitve vseh aktiničnih keratoz na zdravljenem predelu. d Bolniki, pri katerih so v prvem krogu zdravljenja dosegli popolno ozdravitev, vendar so v 26. ali 44. tednu ugotovili ponovitev bolezni.
Areas of skin without any colour (vitiligo), rash, inflamed skin (dermatitis)
predeli kože brez barve (vitiligo), izpuščaj, vnetje kože (dermatitis),
Areas where you may inject Rilonacept Regeneron include the left and right sides of the abdomen, and left and right thighs.
Predeli, kamor lahko injicirate zdravilo Rilonacept Regeneron, vključujejo levo in desno stran trebuha in levo in desno stegno.
Areas with a good amount of fat below the skin (thigh, arm) are the most suitable areas to inject.
Za injiciranje so najbolj primerni predeli z zadostno količino maščobe pod kožo (stegno, roka).
Areas with scars or stretch marks should be avoided.
Izogibajte se predelom z brazgotinami ali strijami.
Areflexia1, headache
arefleksija1, glavobol
Arenda d.o.o
Arenda d.o.o.
Arepanrix (H1N1)
Arepanrix (H1N1) n=164
Arepanrix has been given ‘Conditional Approval’.
Zdravilo Arepanrix je „pogojno odobreno“.
Arepanrix is a vaccine to protect against ‘pandemic’ flu.
Zdravilo Arepanrix je cepivo proti „pandemski“ gripi.
aResponders were defined as those patients who 1) experienced a ≥ 30% drop in VASPI score compared to baseline; 2) had stable or decreased concomitant opioid analgesics; and 3) had opiate type unchanged from preinfusion if receiving opiates.
aKot odzivni bolniki so bili definirani tisti bolniki, ki so 1) izkazali  30-odstotno znižanje VASPI vrednosti glede na izhodiščno vrednost, 2) imeli stabilno ali zmanjšano potrebo po opiatnih analgetikih in 3) v primeru, da so prejemali opiate, niso spremenili tipa opiatov.
aResponders were defined as those who experienced a ≥ 30% drop in VASPI score compared to baseline.
a Kot odzivni bolniki so bili definirani tisti bolniki, ki so izkazali  30-odstotno znižanje VASPI vrednosti glede na izhodiščno vrednost
Arginine 11
Arginin 11
Arginine hydrochloride
argininijev klorid
Arginine supplementation is required for patients diagnosed with deficiency of argininosuccinate synthetase at a dose of 0.4 - 0.7 g/kg/day or 8.8 - 15.4 g/m2/day.
Dopolnjevanje prehrane z argininom je potrebno za bolnike z diagnozo pomanjkljivosti argininosukcinat-sintaze, in sicer z odmerki 0,4 – 0,7 g/kg/dan ali 8,8 – 15,4 g/m2/dan.
Arginine supplementation is required for patients diagnosed with deficiency of argininosuccinate synthetase at a dose of 0.4 - 0.7 g/kg/day or 8.8 - 15.4 g/m2/day.
Dopolnjevanje prehrane z argininom je potrebno za bolnike z diagnozo pomanjkljivosti argininosukcinat-sintaze, in sicer z odmerki 0,4–0,7 g/kg/dan ali 8,8–15,4 g/m2/dan.
Arginine, sodium acetate (E262), sodium chloride, polysorbate 80 (E433), edetate disodium (E386), hydrochloric acid (E507), water for injections.
Arginin, natrijev acetat (E262), natrijev klorid, polisorbat 80 (E433), dinatrijev edetat (E386), klorovodikova kislina (E507), voda za injekcije.
Arginine.
Arginin
argininosuccinic aciduria;
pomanjkanje argininosukcinat-liaze;
ARICLAIM 30 mg hard gastro-resistant capsules
ARICLAIM 30 mg trde gastrorezistentne kapsule
ARICLAIM 30 mg hard gastro-resistant capsules ARICLAIM 60 mg hard gastro-resistant capsules Duloxetine (as hydrochloride)
ARICLAIM 30 mg trde gastrorezistentne kapsule ARICLAIM 60 mg trde gastrorezistentne kapsule duloksetin (v obliki klorida)
ARICLAIM 30 mg hard gastro-resistant capsules Duloxetine
ARICLAIM 30 mg trde gastrorezistentne kapsule duloksetin
ARICLAIM 60 mg hard gastro-resistant capsules
ARICLAIM 60 mg trde gastrorezistentne kapsule
ARICLAIM 60 mg hard gastro-resistant capsules Duloxetine
ARICLAIM 60 mg trde gastrorezistentne kapsule duloksetin
ARICLAIM is a hard gastro-resistant capsule.
Zdravilo ARICLAIM je trda gastrorezistentna kapsula.
ARICLAIM is used in adults to treat a condition called diabetic neuropathic pain (often described as burning, stabbing, stinging, shooting or aching or like an electric shock.
Zdravilo ARICLAIM se uporablja za lajšanje bolečine pri diabetični nevropatiji pri odraslih. (Pogosto jo opisujejo kot pekočo, zbadajočo, pikajočo, prebadajočo ali podobno stresanju elektrike.
ARICLAIM may be taken with or without food.
Zdravilo ARICLAIM lahko vzamete s hrano ali brez nje.
Ariclaim may cause effects that you may not be aware of, such as increases in liver enzymes or blood levels of potassium, creatine phosphokinase, sugar, or cholesterol
Ariclaim lahko povzroči tudi neželene učinke, ki se jih morda ne zavedate, kot povišanje jetrnih encimov ali krvnega nivoja kalija, kreatinske fosfokinaze, sladkorja ali holesterola.
ARICLAIM should not be used in combination with fluvoxamine, ciprofloxacin or enoxacin (i.e. potent CYP1A2 inhibitors) since the combination results in elevated plasma concentrations of duloxetine (see section 4.5).
Zdravila ARICLAIM ne smemo uporabljati v kombinaciji z zaviralci CYP1A2, kot so fluvoksamin, ciprofloksacin ali enoksacin, ker kombinacija povzroči povišane plazemske koncentracije duloksetina (glejte poglavje 4.5).
ARICLAIM should not be used in the treatment of children and adolescents under the age of 18 years.
Zdravila ARICLAIM pri zdravljenju otrok in mladostnikov, mlajših od 18 let, ne smemo uporabljati.
ARICLAIM with food, drink and alcohol
Zdravilo ARICLAIM skupaj s hrano, pijačo in z alkoholom
ARIP IMD 400/300 mg vs.
Preskus Log-Rank
Aripiprazole
Aripiprazol:
Aripiprazole 10 mg (n=27)
aripiprazol
Aripiprazole 10 mg (n=37)
aripiprazol
Aripiprazole Accord 30 mg tablets are pink colored, approximately 9.1 mm in diameter, round shaped, bevelled edge, biconvex, uncoated tablets, debossed with “A30” on one side and another side is plain.
Aripiprazol Accord 30 mg tablete so roza, okrogle, bikonveksne, neobložene tablete z zaobljenim robom, dolžine približno 9,1 mm, z vtisnjeno oznako “A30” na eni strani in brez oznake na drugi strani.
Aripiprazole Accord 5/10/15 mg tablets are also available in HDPE bottle with PPCRC closure containing 30 or 100 tablets.
Aripiprazol Accord 5/10/15 mg tablete so na voljo v HDPE vsebniku z zapiranjem PPCRC v pakiranju po 30 ali 100 tablet.
Aripiprazole Accord contains the active substance aripiprazole and is a ‘generic medicine’.
Zdravilo Aripiprazol Accord vsebuje zdravilno učinkovino aripiprazol in je „generično zdravilo“.
Aripiprazole Accord is effective in a dose range of 10 to 30 mg/day.
Zdravilo Aripiprazol Accord je učinkovito v razponu odmerkov od 10 do 30 mg/dan.
Aripiprazole Accord is for oral use.
Zdravilo Aripiprazol Accord je namenjeno za peroralno uporabo.
Aripiprazole Accord is used in patients aged 15 years or over; bipolar I disorder, a mental illness in which patients have manic episodes (periods of abnormally high mood), alternating with periods of normal mood.
Zdravilo Aripiprazol Accord se uporablja pri bolnikih, starejših od 15 let; bipolarno motnjo I, tj. duševno boleznijo, pri kateri ima bolnik manične epizode (obdobja nenormalno privzdignjenega razpoloženja), ki se izmenjujejo z obdobji normalnega razpoloženja.
Aripiprazole Accord with food, drink and alcohol
Zdravilo Aripiprazol Accord skupaj s hrano, pijačo in alkoholom
Aripiprazole and other antipsychotic active substances should be used cautiously in patients at risk for aspiration pneumonia.
Pri bolnikih s tveganjem za aspiracijsko pljučnico morate aripiprazol in druge antipsihotične učinkovine uporabljati previdno.
Aripiprazole can have minor or moderate influence on the ability to drive and use machines due to potential nervous system and visual effects, such as sedation, somnolence, syncope, vision blurred, diplopia (see section 4.8).
Aripiprazol ima lahko blag ali zmeren vpliv na sposobnost vožnje in upravljanje s stroji zaradi morebitnega vpliva na živčni sistem in vid, kot je sedacija, zaspanost, sinkopa, zamegljen vid in diplopija (glejte poglavje 4.8).
Aripiprazole did not impair fertility based on data from reproductive toxicity studies.
Študije reproduktivne toksičnosti niso pokazale vpliva aripiprazola na plodnost.
Aripiprazole exhibited high binding affinity in vitro for dopamine D2 and D3, serotonin 5HT1a and 5HT2a receptors and moderate affinity for dopamine D4, serotonin 5HT2c and 5HT7, alpha-1 adrenergic and histamine H1 receptors.
In vitro je imel aripiprazol veliko vezavno afiniteto za dopaminske receptorje D2 in D3 in za serotoninske receptorje 5-HT1a in 5-HT2a ter zmerno afiniteto za dopaminske receptorje D4, serotoninske receptorje 5-HT2c in 5-HT7, adrenergične receptorje alfa-1 in histaminske receptorje H1.
Aripiprazole group showed an improvement of 14.97 on TTS-YGTSS change from baseline to week 10 as compared with an improvement of 9.62 in the placebo group.
Pri skupini, ki je prejemala aripiprazol, je bilo10. teden vidno izboljšanje za 14,97 točk po lestvici TTS-YGTSS od izhodiščne vrednosti, v primerjavi z izboljšanjem za 9,62 točke pri skupini, ki je prejemala placebo.
Aripiprazole group showed an improvement of 14.97 on TTS-YGTSS change from baseline to week 10 as compared with an improvement of 9.62 in the placebo group.
Pri skupini, ki je prijemala aripiprazol, je bilo10. teden vidno izboljšanje za 14,97 točk po lestvici TTS-YGTSS od izhodiščne vrednosti, v primerjavi z izboljšanjem za 9,62 točke pri skupini, ki je prejemala placebo.
Aripiprazole is effective in maintaining the clinical improvement during continuation therapy in adult patients who have shown an initial treatment response.
Aripiprazol učinkovito vzdržuje klinično izboljšanje med nadaljevalnim zdravljenjem pri odraslih bolnikih,, ki se uvodoma odzovejo na terapijo.
Aripiprazole is excreted in human milk.
Aripiprazol se izloča v materinem mleku.
Aripiprazole is metabolised by multiple pathways involving the CYP2D6 and CYP3A4 enzymes but not CYP1A enzymes.
Aripiprazol se presnavlja po več poteh, ki vključujejo encime CYP2D6 in CYP3A4, ne pa encimov
Aripiprazole is metabolised by multiple pathways involving the CYP2D6 and CYP3A4 enzymes, but not CYP1A enzymes.
Aripiprazol se presnavlja po več poteh, ki vključujejo encime CYP2D6 in CYP3A4, ne pa encimov
Aripiprazole is not indicated for the treatment of dementia-related psychosis.
Aripiprazol ni indiciran za zdravljenje psihoze, povezane z demenco.
Aripiprazole is not indicated for the treatment of dementia-related psychosis.
Aripiprazol ni indicirano za zdravljenje psihoze, povezane z demenco.
Aripiprazole is not indicated for the treatment of dementia-related psychosis.
Zdravilo ABILIFY ni indicirano za zdravljenje psihoze, povezane z demenco.
Aripiprazole is thought to act mainly by being a ‘partial agonist’ at the receptors for the neurotransmitters dopamine and 5-hydroxytryptamine (also called serotonin).
Aripiprazol domnevno deluje predvsem kot „delni agonist“ receptorjev za nevrotransmitorja dopamin in 5-hidroksitriptamin (imenovan tudi serotonin).
Aripiprazole is thought to act mainly by being a ‘partial agonist’ for the receptors for the neurotransmitters dopamine and 5- hydroxytryptamine (also called serotonin).
Aripiprazol domnevno deluje predvsem kot „delni agonist“ receptorjev za živčna prenašalca dopamin in 5-hidroksitriptamin (imenovan tudi serotonin).
Aripiprazole is thought to act mainly by being a ‘partial agonist’ for the receptors for the neurotransmitters dopamine and 5-hydroxytryptamine (also called serotonin).
Aripiprazol domnevno deluje predvsem kot delni agonist za receptorje za živčna prenašalca dopamin in 5-hidroksitriptamin (imenovanega tudi serotonin).
Aripiprazole Mylan Pharma 10 mg
Aripiprazol Mylan Pharma 10 mg
Aripiprazole Mylan Pharma 10 mg tablets
Aripiprazol Mylan Pharma 10 mg tablete EU/1/15/1005/004
Aripiprazole Mylan Pharma 10 mg tablets are pink, round and biconvex of 8.1mm in diameter, engraved with ‘10’ on one side.
Tablete Aripiprazol Mylan Pharma 10 mg so roza, okrogle in bikonveksne premera 8,1 mm in z vrezano oznako '10' na eni strani.
Aripiprazole Mylan Pharma 10 mg tablets aripiprazole
Aripiprazol Mylan Pharma 10 mg tablete aripiprazol
Aripiprazole Mylan Pharma 15 mg
Aripiprazol Mylan Pharma 15 mg
Aripiprazole Mylan Pharma 15 mg tablets
Aripiprazol Mylan Pharma 15 mg tablete
Aripiprazole Mylan Pharma 15 mg tablets
Aripiprazol Mylan Pharma 15 mg tablete EU/1/15/1005/007
Aripiprazole Mylan Pharma 15 mg tablets are yellow, round and biconvex of 10.1mm in diameter, engraved with ‘15’ on one side.
Tablete Aripiprazol Mylan Pharma 15 mg so rumene, okrogle in bikonveksne premera 10,1 mm in z vrezano oznako '15' na eni strani.
Aripiprazole Mylan Pharma 15 mg tablets aripiprazole
Aripiprazol Mylan Pharma 15 mg tablete aripiprazol
Aripiprazole Mylan Pharma 30 mg
Aripiprazol Mylan Pharma 30 mg
Aripiprazole Mylan Pharma 30 mg tablets
Aripiprazol Mylan Pharma 30 mg tablete EU/1/15/1005/010
Aripiprazole Mylan Pharma 30 mg tablets are pink, oval and biconvex of 17.1mm in length, 8.1mm in width, engraved with ‘30’ on one side.
Tablete Aripiprazol Mylan Pharma 30 mg so roza, ovalne in bikonveksne dolžine 17,1 mm širine 8,1 mm ter z vrezano oznako '30' na eni strani.
Aripiprazole Mylan Pharma 30 mg tablets aripiprazole
Aripiprazol Mylan Pharma 30 mg tablete aripiprazol
Aripiprazole Mylan Pharma 5 mg
Aripiprazol Mylan Pharma 5 mg
Aripiprazole Mylan Pharma 5 mg tablets
Aripiprazol Mylan Pharma 5 mg tablete
Aripiprazole Mylan Pharma 5 mg tablets
Aripiprazol Mylan Pharma 5 mg tablete EU/1/15/1005/001
Aripiprazole Mylan Pharma 5 mg tablets aripiprazole
Aripiprazol Mylan Pharma 5 mg tablete aripiprazol
Aripiprazole Mylan Pharma 5 mg tablets Aripiprazole Mylan Pharma 10 mg tablets Aripiprazole Mylan Pharma 15 mg tablets Aripiprazole Mylan Pharma 30 mg tablets
Aripiprazol Mylan Pharma 5 mg tablete Aripiprazol Mylan Pharma 10 mg tablete Aripiprazol Mylan Pharma 15 mg tablete Aripiprazol Mylan Pharma 30 mg tablete
Aripiprazole Mylan Pharma 5 mg tablets Each tablet contains 5 mg of aripiprazole.
Aripiprazol Mylan Pharma 5 mg tablete Ena tableta vsebuje 5 mg aripiprazola.
Aripiprazole Mylan Pharma contains the active substance aripiprazole and is a ‘generic medicine’.
Zdravilo Aripiprazol Mylan Pharma vsebuje zdravilno učinkovino aripiprazol in je „generično zdravilo“.
Aripiprazole Mylan Pharma is used in patients aged 15 years or over; bipolar I disorder, a mental illness in which patients have manic episodes (periods of abnormally high mood), alternating with periods of normal mood.
Zdravilo Aripiprazol Mylan Pharma se uporablja pri bolnikih, starih 15 let ali več; bipolarno motnjo I, tj. duševno boleznijo, pri kateri ima bolnik manične epizode (obdobja nenormalno privzdignjenega razpoloženja), ki se izmenjujejo z obdobji normalnega razpoloženja.
Aripiprazole Mylan Pharma tablets are used to treat adults and adolescents aged 13 years and older who suffer from a condition with symptoms such as feeling "high", having excessive amounts of energy, needing much less sleep than usual, talking very quickly with racing ideas and sometimes severe irritability.
Zdravilo Aripiprazol Mylan Pharma tablete uporabljamo za zdravljenje odraslih in mladostnikov, starih 13 let in več, ki imajo težave s simptomi, kot so evforično razpoloženje, pretirana energija, zmanjšana potreba po spanju, hitro govorjenje s prehitevajočimi mislimi in občasno huda razdražljivost.
Aripiprazole Mylan Pharma tablets contain maltose
Zdravilo Aripiprazol Mylan Pharma vsebuje maltozo
Aripiprazole Mylan Pharma tablets contain the active substance aripiprazole and belong to a group of medicines called antipsychotics.
Zdravilo Aripiprazol Mylan Pharma tablete vsebuje zdravilno učinkovino aripiprazol in spada v skupino zdravil, imenovanih antipsihotiki.
Aripiprazole Mylan Pharma1 aripiprazole
Aripiprazol Mylan Pharma1 aripiprazol
Aripiprazole Sandoz 10 mg tablets are pink coloured, mottled, round shaped tablets, with an approximate diameter of 6.0 mm, debossed with “SZ” on one side and “446” on the other side.
Tablete Aripiprazol Sandoz 10 mg so rožnate lisaste okrogle tablete s približnim premerom 6,0 mm, z vtisnjeno oznako “SZ” na eni strani in “446” na drugi strani.
Aripiprazole Sandoz 15 mg tablets are yellow coloured, mottled, round shaped tablets, with an approximate diameter of 7.0 mm, debossed with “SZ” on one side and “447” on the other side.
Tablete Aripiprazol Sandoz 15 mg so rumene lisaste okrogle tablete s približnim premerom 7,0 mm, z vtisnjeno oznako “SZ” na eni strani in “447” na drugi strani.
Aripiprazole Sandoz 20 mg tablets are white coloured, round shaped tablets, with an approximate diameter of 7.8 mm, debossed with “SZ” on one side and “448” on the other side.
Tablete Aripiprazol Sandoz 20 mg so bele okrogle tablete s približnim premerom 7,8 mm, z vtisnjeno oznako “SZ” na eni strani in “448” na drugi strani.
Aripiprazole Sandoz 30 mg tablets are pink coloured, mottled, round shaped tablets, with an approximate diameter of 9.0 mm, debossed with “SZ” on one side and “449” on the other side.
Tablete Aripiprazol Sandoz 30 mg so rožnate lisaste okrogle tablete s približnim premerom 9,0 mm, z vtisnjeno oznako “SZ” na eni strani in “449” na drugi strani.
Aripiprazole Sandoz contains the active substance aripiprazole and is a ‘generic’ and a ‘hybrid’ medicine.
Zdravilo Aripiprazole Sandoz vsebuje zdravilno učinkovino aripiprazol in je „generično“ in „hibridno“ zdravilo.
Aripiprazole Sandoz is used in patients aged 15 years or over; bipolar I disorder, a mental illness in which patients have manic episodes (periods of abnormally high mood), alternating with periods of normal mood.
Zdravilo Aripiprazole Sandoz se uporablja pri bolnikih, starih 15 let ali več; bipolarno motnjo I, tj. duševno boleznijo, pri kateri ima bolnik manične epizode (obdobja nenormalno privzdignjenega razpoloženja), ki se izmenjujejo z obdobji normalnega razpoloženja.
Aripiprazole Sandoz tablets are used to treat adults and adolescents aged 13 years and older who suffer from a condition with symptoms such as feeling "high", having excessive amounts of energy, needing much less sleep than usual, talking very quickly with racing ideas and sometimes severe irritability.
Zdravilo Aripiprazol Sandoz tablete uporabljamo za zdravljenje odraslih in mladostnikov, starih 13 let in več, ki imajo težave s simptomi, kot so evforično razpoloženje, pretirana energija, zmanjšana potreba po spanju, hitro govorjenje s prehitevajočimi mislimi in občasno huda razdražljivost.
Aripiprazole Sandoz tablets contain lactose
Zdravilo Aripiprazol Sandoz tablete vsebuje laktozo
Aripiprazole Sandoz tablets contain the active substance aripiprazole and belong to a group of medicines called antipsychotics.
Zdravilo Aripiprazol Sandoz tablete vsebuje zdravilno učinkovino aripiprazol in spada v skupino zdravil, imenovanih antipsihotiki.